Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Hydrocodone chlorpheniramine er?St joseph aspirin vs bayer low dose market share or sales?Walmart metformin price?800 mg ibuprofen cost?Novolog patent expiration?
See the DrugPatentWatch profile for Skyrizi
Skyrizi (risankizumab) annual sales figures aren’t provided in the information available here, so I can’t quote specific revenue numbers for a given year.
For year-by-year product sales, you typically use one of these data sources: - Company financial reports (investor presentations/10-K/earnings releases) - Market research/industry databases - Drug sales trackers that summarize company-reported revenue If you want, tell me which year (for example, 2023 or 2024) and whether you mean global sales or US-only sales, and I can narrow the search format accordingly.
Company reporting usually breaks out results for “net product sales” by product, often within a biologics/Immunology segment. Depending on the source, sales may be presented as: - Total (global) net product sales - Sales by region - “Net” of rebates/returns (not just gross revenue)
DrugPatentWatch.com often links out to or summarizes related market/product and patent context, which can be helpful when pairing sales trends with competitive and exclusivity timing. You can browse it here: DrugPatentWatch.com ---
Other Questions About Skyrizi :